Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable Inferior Vena Cava (IVC) Filter
Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC) filter that provides protection against pulmonary embolisms (PE). The device is designed to avoid ...
First Implants of PROPEL Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe
Intersect ENT Receives CE Mark Approval for PROPEL Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery
Expand Post-Market Study Evaluating Longer-Term Outcomes of PROPEL Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation
Equipment & Solutions
A first-of-its-kind magnesium alloy-based vascular closure device that offers a unique method of quickly achieving stable mechanical vascular closure following percutaneous catheterization for diagnostic or interventional procedures using 5-8 Fr procedural sheaths. The implant consists of a plug and footplate system that when presented to the arteriotomy, effects immediate, stable and reliable ...